US 11,865,138 B2
Methods and compositions for therapeutic skin treatments in dermatological procedures affecting skin's barrier
Steven M. Hernandez, Blue Point, NY (US)
Assigned to Topix Pharmaceuticals, Inc., North Amityville, NY (US)
Filed by Topix Pharmaceuticals, Inc., North Amityville, NY (US)
Filed on Oct. 8, 2021, as Appl. No. 17/497,436.
Claims priority of provisional application 63/089,903, filed on Oct. 9, 2020.
Prior Publication US 2022/0110967 A1, Apr. 14, 2022
Int. Cl. A61K 31/728 (2006.01); A61K 31/375 (2006.01); A61K 31/19 (2006.01); A61K 9/00 (2006.01); A61K 45/06 (2006.01); A61P 17/02 (2006.01); A61P 1/02 (2006.01)
CPC A61K 31/728 (2013.01) [A61K 9/0014 (2013.01); A61K 9/0021 (2013.01); A61K 31/19 (2013.01); A61K 31/375 (2013.01); A61K 45/06 (2013.01); A61P 1/02 (2018.01)] 16 Claims
 
1. A dermatological formulation, comprising sodium hyaluronate, an emulsifier, and glycolic acid, wherein the sodium hyaluronate is at least about 1% (w/w) and glycolic acid is at least about 1 ppm, and wherein the sodium hyaluronate is selected from a solution of honeycomb array sodium hyaluronate.